Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, ...
Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...
May is Celiac Disease Awareness Month. When it comes to celiac disease, there is so much to be aware of for everyone, those ...
Scientists recently discovered that glycyrrhizin, a substance taken from black licorice root, may reduce inflammation and ...
A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
What Is Crohn’s Constipation? You likely have constipation if it's hard for you to poop and you're having fewer bowel movements than you normally do. The same is true whether or not you have Crohn’s ...
The terms "intestinal barrier" and "intestinal permeability" describe two different aspects of the same anatomical structure, the intestinal wall composed of four layers, the mucosa, the submucosa, ...
Surgeons commonly perform a prostatectomy to treat prostate cancer. It involves removing all or part of the prostate. However, prostate removal may cause bowel problems in some people. A prostatectomy ...
UPADACITINIB acne affected nearly half of surveyed patients with IBD and sometimes changed treatment decisions. Upadacitinib Acne Emerges as Common Real-World Concern. Upadacitini ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results